Results 191 to 200 of about 676,827 (333)

HLA-J, A SECOND INACTIVATED CLASS I HLA GENE RELATED TO HLA-G AND HLA-A [PDF]

, 1992
Girdlestone, J., Messer, Gerald, Orr, Harry T., Parham, P., Weiss, Elisabeth H., Zemmour, Jaqueline   +5 more
core   +1 more source

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Advanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi   +5 more
wiley   +1 more source

deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types. [PDF]

Clin Transl Med
Xu J, Wei X, Yao J, Mahajan UM, Kahlert UD, Shi R, Zhang K, Alnatsha A, Qian Z, Han F, Wang F.   +10 more
europepmc   +1 more source

Machine Learning‐Enhanced Random Matrix Theory Design for Human Immunodeficiency Virus Vaccine Development

Advanced Intelligent Discovery, EarlyView.
This study integrates random matrix theory (RMT) and principal component analysis (PCA) to improve the identification of correlated regions in HIV protein sequences for vaccine design. PCA validation enhances the reliability of RMT‐derived correlations, particularly in small‐sample, high‐dimensional datasets, enabling more accurate detection of ...
Mariyam Siddiqah, Muhammad Zulqarnain Zeb, Muhammad Husnain Zeb, Babar Shabbir   +3 more
wiley   +1 more source

Steroid Phenotype Stratification Reveals Distinct HLA Expression Signatures in Adrenocortical Carcinoma. [PDF]

Cancers (Basel)
Giner IS, Resende JSS, Muzzi JCD, Barbuto JAM, Lalli E, Castro MAA, Figueiredo BC.   +6 more
europepmc   +1 more source

Association Between HLA Alleles and IgA Nephropathy in a Taiwanese Population. [PDF]

Int J Mol Sci
Huang YC, Chen IC, Lin GC, Hsiao TH, Tsai SF, Chen YM, Fu LS.   +6 more
europepmc   +1 more source

The Tübingen approach: identification, selection and validation of tumor-associated HLA peptides for cancer therapy [PDF]

, 2004
Harpreet Singh, Toni Weinschenk, Claudia Lemmel, Oliver Schoor, Jörn Dengjel, Cécile Gouttefangeas, Stefan Stevanović, Peter Brossart, H-G Rammensee   +8 more
openalex   +1 more source

Author Response: Morphea, Gluten, and Autoimmunity: HLA Behind the Scenes?

, 2021
Mitchell Davis, Brett C. Neill, Atieh Jibbe, Stanislav N. Tolkachjov   +3 more
openalex   +2 more sources

Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial

American Journal of Hematology, EarlyView.
ABSTRACT Non‐severe aplastic anemia (NSAA) is a heterogeneous bone marrow failure syndrome with limited standardized treatment options. Cyclosporine A (CsA) monotherapy often yields suboptimal responses, highlighting an unmet clinical need for more effective therapies.
Lele Zhang, Ruonan Li, Qian Liang, Weiwang Li, Hong Pan, Zhen Gao, Liwei Fang, Jingyu Zhao, Xiao Yu, Zhexiang Kuang, Neng Nie, Jianping Li, Jinbo Huang, Xin Zhao, Meili Ge, Yizhou Zheng, Jun Li, Hong Zhang, Jun Shi   +18 more
wiley   +1 more source

HLA-Knockout: Enabling Allele-Specific Knockout of HLA Class I Genes for Immunogenic Engineering. [PDF]

HLA
Mattivi C, Wang S, Ji L, Xiao Q, Cao J.
europepmc   +1 more source